Gastroesophageal reflux disease in patients with metabolic syndrome: the peculiarities of clinical course and the modern approaches to treatment
Journal Title: Сучасна гастроентерологія - Year 2018, Vol 0, Issue 4
Abstract
The article presents a data on prevalence of gastroesophageal reflux disease and Barrett’s esophagus in patients with metabolic syndrome. The main etiopathogenetic mechanisms of formation and modern approaches to therapy of gastroesophageal reflux in patients with metabolic syndrome have been considered. The issues of drug interactions, as well as the mechanisms of metabolism of pharmacological agents in patients with metabolic syndrome have been discussed. The substantiation has been given to the administration of pantoprazole (Zolopent) as a medication with minimal side effects, without interaction with other medicinal agents and suitable for the long-term treatment of the gastroesophageal reflux disease and Barrett’s esophagus in patients with metabolic syndrome.
Authors and Affiliations
L. V. Zhuravlyova, M. V. Filonenko
Keywords
Related Articles
- EP ID EP417772
- DOI 10.30978/MG-2018-3-90
- Views 136
- Downloads 0
Influence of non-alcoholic fatty liver disease on the cardiac hemodynamics indices and vascular disorders in patients with essential hypertension
Objective — to compare the structural and functional state of the heart, vessels and liver in patients with isolated EH and in conditions of its combination with NAFLD. Materials and methods. A total of 117 patients wit...
How pharmacokinetics of 5-ASA preparations affects their efficacy?
_
Treatment of the irritable bowel syndrome: the role of probiotics
Currently, the irritable bowel syndrome (IBS) ranks first in the chronic bowel diseases. Its prevalence varies 1 to 36 % and is about 7 % at average The problems of IBS diagnosis and treatment remain relevant in the mode...
The post-infection syndrome of the irritable bowel: recent recommendations of the Rome Foundation Working team
The presence of such form of the irritable bowel syndrome (IBS) as a post-infection IBS (PI — IBS) was proved a long time ago in the clinical-laboratory and epidemiological investigations, conducted in various geographic...
The role and place of Actovegin in the complex therapy of cytokine metabolism in patients with GERD with concomitant bronchial asthma
Objective — to study the advisability of the Actovegin inclusion in the standard treatment regimen for patients with GERD and concomitant mild to moderate BA in terms of its effects on the clinical course of this comorbi...